The eosinophil/mast cell chemokine receptor CCR3 is specifically expressed in choroidal neovascular endothelial cells in humans with AMD, and genetic or pharmacological targeting of CCR3 or eotaxin inhibited injury induced CNV in mice (Takeda et al., 2009). The gene discussed is CCR3; the disease is age-related macular degeneration.